OEM News, People

Lisa Wolf Named Interim CFO at Tivic Health

Wolf’s predecessor continues with the company as an advisor focused on strategic transactions and special projects.

By: Michael Barbella

Managing Editor

Tivic Health Systems Inc. has appointed Lisa Wolf as interim chief financial officer (CFO), effective Oct. 1, succeeding Kimberly Bambach, who had held the position since April 2023. Bambach will continue with Tivic in an advisory role for strategic transactions and other special projects.
 
“Lisa has served as a senior member of Tivic’s finance team for over two years, and I am delighted to have her taking on an even more pivotal role. I look forward to working with her to lead the company into our next phase of growth in bioelectronic therapeutics,” Tivic CEO Jennifer Ernst said.
 
Wolf has 30 years of financial leadership experience in public and private companies spanning multiple industries. She has built a deep understanding of Tivic’s financial landscape during her tenure serving the company and has a history of significant contributions, including streamlining the company’s financial operations. Wolf also currently serves as vice president of Murdock Martell and has previously held positions at Resonant Inc. and Arthur Andersen.
 
Bambach is now a company advisor, focusing on strategic transactions and other special projects. “I am also deeply grateful for Kimberly Bambach’s contributions over the past 18 months as we restructured the company to better address current and future market opportunities. I am very pleased she will continue with us in this advisory capacity,” Ernst stated.
 
Tivic Health is a commercial health tech company advancing bioelectronic medicine. Tivic Health’s technology platforms leverage stimulation of the trigeminal, sympathetic, and vagus nerve structures. Tivic Health’s non-invasive and targeted approach to the treatment of inflammatory chronic health conditions gives consumers and providers drug-free therapeutic solutions with high safety profiles, low risk, and broad applications. Tivic Health’s first commercial product ClearUP is a U.S. Food and Drug Administration-approved handheld bioelectronic sinus device. ClearUP is clinically proven, doctor-recommended, and is available through online retailers and commercial distributors. 
 

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters